| Application no. and date | 20157813.5 (espacenet) (Federated) (European Patent Register), 20130621 | | Patent/reg. no. and date | DK/EP 3689365, 20250806 | | Publication date | 20200805 | | Priority no. and date | EP 12174535, 20120701, US 201261694837 P, 20120830, EP 12186781, 20121001, US 201261708162 P, 20121001 | | EP pub. no. and date |
EP 3689365 20200805 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, DK | | Applicant ref. no. | | | Inventor | JENSEN, Christine Bjørn, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
RASMUSSEN, Mads Frederik, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
ZDRAVKOVIC, Milan, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
KRISTENSEN, Peter, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK | | Representative | | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61P 3/04 (2006.01) | | Title | USE OF LONG-ACTING GLP-1 PEPTIDES | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
